This is Noxopharm Limited
A company aiming to create a drug to treat cancer in an innovative way that we believe will bring significant change to the management of cancer.
Latest News
More News

CEO Blog

View more

Share Price Chart

Market Cap:
Price Delayed by ~20min

*market cap above based on the number of quoted shares (i.e. non-escrow stock)

Investor Information

ASX Announcements

read more


FNN Interviews Noxopharm CMO about Interim DARRT-1 Trial Data

St Vincent's Hospital Principal Investigator Discussed LuPIN-1 Study

Upcoming Events

FNN- Shaw & Partners Investor Event
Tuesday 26 February 2019, 12.30-2.30pm
Radisson Blu Plaza Hotel Sydney

AusBiotech Asian Investment Series Hong Kong and Shanghai, China March 26, 28-29 2019